The product that makes ExactCare legible is a cardboard dispenser filled with little labeled packets. Tear at the perforation. Tuesday, 8 a.m. is in your hand. For a patient juggling prescriptions from a primary-care doctor, a cardiologist and a specialist, this is pleasingly concrete. Yet the packet is almost a decoy. ExactCare's real product is the choreography required to make that packet correct: interviewing the patient, reconciling the medication list, chasing renewals, synchronizing refill dates, checking therapy, coordinating changes and getting the next 30 days to the right door.
That makes the Cleveland company less like a prettier mail-order pharmacy and more like an operating system for polypharmacy. It serves people with chronic conditions and complex medical needs, particularly those taking many medications or moving between a hospital, facility and home. It also sells the outcome upstream. Health plans, home-health agencies, hospitals, PACE programs and risk-bearing providers use or refer to ExactCare because a missed dose can become their missed quality measure, emergency visit or avoidable inpatient day.
A pharmacist who would not stop at the counter
Founder Dale Wollschleger did not arrive from Silicon Valley with a theory of digital therapeutics. He was a pharmacist. After growing Lutheran Family Pharmacy, he bought it in the mid-2000s. Working with psychiatric patients on several medications, he saw a routine failure: every prescription could be valid while the combined regimen remained bewildering. Patients went to a pharmacy, as he later put it, but did not necessarily feel they had a pharmacist responsible for the whole picture.
The first business branch he abandoned was a durable medical equipment company started behind the neighborhood pharmacy. In a 2025 interview, Wollschleger recalled deciding that it was not the path, selling that venture and another pharmacy while keeping Lutheran. ExactCare began in Lutheran's back room in 2009. The change of mind was not a grand retreat from healthcare. It was a narrowing: complex medication routines were the recurring problem he understood closely enough to build around.
“I wanted to make it easier and safer for patients to take multiple medications.”Dale Wollschleger, founder, in 2014
The model combined a health and medication review with reconciliation, prescription synchronization, recurring pharmacist review, refill management, customized ExactPack packaging and home delivery. A second test in New Jersey mattered. Wollschleger and a colleague bought a small hometown pharmacy and ran another ExactCare operation from the back. It worked. That repeatability changed the ambition. The company hired a CFO, brought in outside capital, obtained licenses across the country, placed clinical liaisons in new markets and built software and automation around work that had begun on paper.
The interface is paper. The moat is follow-through.
Competitors can copy a packet. Amazon's PillPack made dose packaging familiar; MedMinder adds connected dispensers; retail and mail pharmacies can ship 90-day bottles. ExactCare's difference is the target customer and the labor wrapped around fulfillment. A typical user is not merely busy. The company says its service is designed for people with multiple conditions, prescribers and daily doses, often with a caregiver involved. ExactCare maintains a closed-door operation rather than a walk-in store, with fulfillment sites in Ohio and Texas and pharmacy-board licenses in every state and Washington, D.C.
At intake, a clinical liaison gathers medical and insurance information. Pharmacists review therapy and work with prescribers. The company aligns prescriptions to a monthly cycle, packages routine doses, can leave some medicines in bottles when appropriate, and handles ongoing renewal outreach. Patients get delivery tracking, medication images, reminders, messages, billing and account information in the ExactCare app. A pharmacist is available on call for urgent needs around the clock. This is not glamorous software. It is software attached to people who answer phones and to licensed facilities that cannot improvise.
What it costs, and who pays
For a patient, the proposition is unusually easy to state. ExactCare accepts most major insurance plans, including Medicare Part D and Medicaid. The patient owes the copays determined by the insurance plan and pays for non-prescription items the plan does not cover. ExactCare says it charges nothing additional for its packaging, delivery or clinical services, and there is no long-term contract. That does not mean every prescription becomes cheaper. It means the service layer is bundled into the pharmacy relationship rather than sold as a premium subscription.
The business earns pharmacy revenue by dispensing medications and billing insurers, and it also works with healthcare organizations on adherence, transition and population-health programs. Contract terms are private. The model is therefore both consumer-facing and institutional: win the patient's trust, then demonstrate value to the organization carrying clinical and financial risk.
The corporate price tag is a different matter. Primus Capital took a minority interest in 2014. Nautic Partners recapitalized ExactCare with Primus in 2016 and remains the controlling owner of its parent. In 2023, Nautic acquired public company Tabula Rasa HealthCare and combined it with ExactCare. That all-cash deal valued Tabula Rasa at roughly $570 million including about $262 million of net debt. It was the cost of the target, not a valuation of ExactCare. The combined business adopted the AnewHealth name in 2024, while ExactCare remained its at-home pharmacy brand.
The evidence is promising - and narrower than the sales pitch
A RAND-led study published in 2021 offers the most useful test. Researchers matched 701 ExactCare participants with 1,395 comparison patients using insurer data. After one year, ExactCare participation was associated with an 8.4 percentage-point improvement in statin adherence and a 4.9-point improvement for antihypertensive drugs. The diabetes-drug adherence change was not statistically significant.
The study also associated participation with fewer skilled-nursing admissions, fewer inpatient days and fewer skilled-nursing days. Total cost fell by $196 per member per month, about $2,400 a year or 5 percent on average. Prescription spending actually rose by $30 per member per month while medical spending fell by $226. That is ExactCare's economic argument in miniature: taking more of the right medicine can increase the pharmacy line while shrinking the facility bill.
Keep the decimal points honest. This was an observational matched study, not a randomized trial. ExactCare funded the research under a contract that left study design, analysis, drafting and publication decisions with the researchers. Emergency-department visits and hospital-admission rates did not show significant reductions. The strongest reading is association with several meaningful improvements, not proof that every population or plan will save the same amount.
The acquisition era
Scale changed the company twice. First, private equity supplied the systems and capital to move beyond founder-led improvisation. Wollschleger's copyable management lesson is blunt: hire people who have already seen the next stage, then combine their experience with what the company learned on the ground. Second, ExactCare's parent stopped treating national dispensing as the whole platform.
Tabula Rasa brought medication-risk technology, PACE expertise and pharmacy-benefit management. AnewHealth then acquired HomeFree Pharmacy Services in 2024 and folded it toward the ExactCare home model. At the time, HomeFree served nearly 5,000 patients in 33 states; the combined parent said it served nearly 110,000 people. The strategy is straightforward: put dispensing, clinical pharmacy, risk science and benefit administration under one roof for the medically complex populations that value-based care organizations worry about most.
There is an identity cost. ExactCare is now “a pharmacy by AnewHealth,” and the leadership has moved beyond the founder. Wollschleger stepped away as CEO and remained involved at board level; Brian Adams became AnewHealth CEO in 2025 after John Figueroa retired. The original product survives, but it sits inside a broader company whose vocabulary includes PBM, PACE and medication-risk platforms. The little packet now carries a lot of corporate architecture.
What another operator can steal
Five reusable moves
- Choose a recurring failure, not a vague aspiration. ExactCare centered the next dose and the next refill, not “better health” in the abstract.
- Fix inputs before polishing outputs. A beautiful packet is unsafe if the medication list is wrong. Reconciliation comes first.
- Synchronize the calendar. Moving scattered refills onto one cadence removes dozens of small decisions.
- Keep humans at the exception points. Software handles reminders and visibility; pharmacists and support teams handle changes, conflicts and prescribers.
- Sell the second-order result. The patient buys simplicity. The plan cares about adherence, quality scores and avoided facility use.
This pattern travels beyond pharmacy. Tax firms, eldercare services, insurance brokers and compliance teams all deal with recurring high-stakes routines fed by messy information. The transferable move is to wrap the transaction in intake, coordination, exception handling and follow-up until the customer no longer has to be the project manager.
When it will not work
Wrong customer
Someone taking one stable daily prescription may prefer a local counter or a 90-day bottle. ExactCare's coordination layer earns its keep when the regimen is genuinely complex.
Fast-changing regimen
Frequent acute changes can collide with a prepacked monthly cycle. The pharmacy can send interim bottles, but patients and prescribers must communicate quickly.
Weak participation
The model depends on accurate medication lists, returned calls, valid prescriptions, insurance coverage and a safe delivery address. Packaging cannot repair missing inputs.
No accountable payer
The B2B case is weaker where nobody shares savings from better adherence or avoided utilization. Complex service needs an economic beneficiary, not just goodwill.
Nor should dose packaging be mistaken for medical advice. A patient's pharmacist and prescribers still decide what belongs in the regimen. ExactCare's advantage is not making that decision alone. It is keeping everyone close enough to the same list that Tuesday morning has a fighting chance of being boring.
A modest object with a large job
ExactCare fits between retail pharmacy, long-term-care pharmacy, mail order and care management. That awkward middle is precisely the opportunity. Retail is optimized for transactions. Traditional long-term care is optimized for facilities. Consumer pill packs are optimized for convenience. ExactCare is optimized for a medically complicated person living at home, plus the family and institutions trying to keep that person there.
The company did not remove complexity from healthcare. It moved complexity away from the kitchen table and into an organization built to process it repeatedly. The achievement is not that a box can tell someone which packet to open. It is that a pharmacist, a fulfillment line, a prescriber, a payer and a delivery network can agree on what goes inside before the perforation tears.